Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Schedules to Balance Sheetas at 31st March 20<strong>11</strong>SCHEDULE 1SHARE CAPITAL :As at31st March 20<strong>11</strong>(` in Lacs)As at31st March 20<strong>10</strong>AUTHORISED :` 3,000.00 ` 3,000.00 ISSUED, SUBSCRIBED AND PAID - UP :` 2,053.69 ` 2.98 SCHEDULE 2RESERVES AND SURPLUS :2,056.67 SHARE PREMIUMOpening Balance 18,272.80 6,801.77 25,074.57 HEDGING RESERVE 501.29 GENERAL RESERVEOpening Balance 9,<strong>11</strong>8.51 3,000.00 12,<strong>11</strong>8.51 (1,236.<strong>10</strong>) <strong>10</strong>,882.41 DEBENTURE REDEMPTION RESERVE 4,000.00 –PROFIT AND LOSS ACCOUNT 18,596.86 59,055.13 58
Change language